AmerisourceBergen Corporation Profile Avatar - Palmy Investing

AmerisourceBergen Corporation

AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home…
Medical - Distribution
US, Conshohocken [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 14% Weak
Profitability n.A. n.A.
Fin. Growth 17% Weak
Leverage & Liquidity 33% Weak
Per Share Metrics 33% Weak
Fin. Health n.A. n.A.
1 Financial Health
Metric Q1 Q2 Δ in %
Current Ratio 0.45 0.89 0.88
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 57.45 2.77 1.76
Naive Interpretation member
2 Per Share
Metric Q1 Q2 Δ in %
Book Value 35.04 6.15 4.56
Cash -30.16 10.38 14.85
Capex -52.44 -0.57 -0.37
Free Cash Flow 22.64 -4.97 4.05
Revenue -4.99 343.09 361.12
Naive Interpretation member
3 Profitability
Metric Q1 Q2 Δ in %
Gross Margin 11.33 0.03 0.03
Operating Margin 23.36 0.01 0.01
ROA -29.15 < 0.005 < 0.005
ROE -48.02 0.34 0.66
ROIC 20.24 0.12 0.10
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of ABC is permitted for members.
5 Growth
The "Growth Entry" for the Focus of ABC is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of ABC is permitted for members.
End of ABC's Analysis
CIK: 1140859 CUSIP: 03073E105 ISIN: US03073E1055 LEI: - UEI: -
Secondary Listings
ABC has no secondary listings inside our databases.